252 related articles for article (PubMed ID: 33641289)
1. Real life study of the use of omalizumab for pediatric patients with multiple food allergies.
Crespo JB; Domingo MV; Arauzo NH; Castillo MJ; Delavalle MB; Foix MPS; Sánchez DV; Izquierdo-Domínguez A
Allergol Immunopathol (Madr); 2021; 49(2):15-22. PubMed ID: 33641289
[TBL] [Abstract][Full Text] [Related]
2. Effects of omalizumab in patients with food allergy.
Rafi A; Do LT; Katz R; Sheinkopf LE; Simons CW; Klaustermeyer W
Allergy Asthma Proc; 2010; 31(1):76-83. PubMed ID: 20167148
[TBL] [Abstract][Full Text] [Related]
3. Individually dosed omalizumab: an effective treatment for severe peanut allergy.
Brandström J; Vetander M; Lilja G; Johansson SG; Sundqvist AC; Kalm F; Nilsson C; Nopp A
Clin Exp Allergy; 2017 Apr; 47(4):540-550. PubMed ID: 27883239
[TBL] [Abstract][Full Text] [Related]
4. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
Guilleminault L; Michelet M; Reber LL
Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
[TBL] [Abstract][Full Text] [Related]
5. Use of omalizumab in the treatment of food allergy and anaphylaxis.
Lieberman JA; Chehade M
Curr Allergy Asthma Rep; 2013 Feb; 13(1):78-84. PubMed ID: 23065311
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab for the Treatment of Multiple Food Allergies.
Wood RA; Togias A; Sicherer SH; Shreffler WG; Kim EH; Jones SM; Leung DYM; Vickery BP; Bird JA; Spergel JM; Iqbal A; Olsson J; Ligueros-Saylan M; Uddin A; Calatroni A; Huckabee CM; Rogers NH; Yovetich N; Dantzer J; Mudd K; Wang J; Groetch M; Pyle D; Keet CA; Kulis M; Sindher SB; Long A; Scurlock AM; Lanser BJ; Lee T; Parrish C; Brown-Whitehorn T; Spergel AKR; Veri M; Hamrah SD; Brittain E; Poyser J; Wheatley LM; Chinthrajah RS
N Engl J Med; 2024 Mar; 390(10):889-899. PubMed ID: 38407394
[TBL] [Abstract][Full Text] [Related]
7. Impact of Omalizumab on Food Allergy in Patients Treated for Asthma: A Real-Life Study.
Fiocchi A; Artesani MC; Riccardi C; Mennini M; Pecora V; Fierro V; Calandrelli V; Dahdah L; Valluzzi RL
J Allergy Clin Immunol Pract; 2019; 7(6):1901-1909.e5. PubMed ID: 30797778
[TBL] [Abstract][Full Text] [Related]
8. Reactions of Buckwheat-Hypersensitive Patients during Oral Food Challenge Are Rare, but Often Anaphylactic.
Yanagida N; Sato S; Takahashi K; Nagakura KI; Ogura K; Asaumi T; Ebisawa M
Int Arch Allergy Immunol; 2017; 172(2):116-122. PubMed ID: 28268211
[TBL] [Abstract][Full Text] [Related]
9. Increasing specific immunoglobulin E levels correlate with the risk of anaphylaxis during an oral food challenge.
Yanagida N; Sato S; Takahashi K; Nagakura KI; Asaumi T; Ogura K; Ebisawa M
Pediatr Allergy Immunol; 2018 Jun; 29(4):417-424. PubMed ID: 29575164
[TBL] [Abstract][Full Text] [Related]
10. Anaphylaxis Refractory to intramuscular adrenaline during in-hospital food challenges: A case series and proposed management.
Alviani C; Burrell S; Macleod A; Edees S; Roberts G; Turner PJ; Erlewyn-Lajeunesse M
Clin Exp Allergy; 2020 Dec; 50(12):1400-1405. PubMed ID: 32997857
[TBL] [Abstract][Full Text] [Related]
11. Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
Andorf S; Purington N; Block WM; Long AJ; Tupa D; Brittain E; Rudman Spergel A; Desai M; Galli SJ; Nadeau KC; Chinthrajah RS
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):85-94. PubMed ID: 29242014
[TBL] [Abstract][Full Text] [Related]
12. IgE-Mediated Food Allergy.
Anvari S; Miller J; Yeh CY; Davis CM
Clin Rev Allergy Immunol; 2019 Oct; 57(2):244-260. PubMed ID: 30370459
[TBL] [Abstract][Full Text] [Related]
13. A practical guide for implementing omalizumab therapy for food allergy.
Casale TB; Fiocchi A; Greenhawt M
J Allergy Clin Immunol; 2024 Jun; 153(6):1510-1517. PubMed ID: 38599291
[TBL] [Abstract][Full Text] [Related]
14. Epinephrine use in positive oral food challenges performed as a screening test for food allergy therapy trials.
Noone S; Ross J; Sampson HA; Wang J
J Allergy Clin Immunol Pract; 2015; 3(3):424-8. PubMed ID: 25609353
[TBL] [Abstract][Full Text] [Related]
15. Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Palgan K; Bartuzi Z; Gotz-Zbikowska M
Int J Immunopathol Pharmacol; 2014; 27(1):109-12. PubMed ID: 24674685
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab in children with severe allergic disease: a case series.
Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
[TBL] [Abstract][Full Text] [Related]
17. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009.
Sicherer SH; Leung DY
J Allergy Clin Immunol; 2010 Jan; 125(1):85-97. PubMed ID: 20109740
[TBL] [Abstract][Full Text] [Related]
18. Factors impacting parental burden in food-allergic children.
Allen CW; Bidarkar MS; vanNunen SA; Campbell DE
J Paediatr Child Health; 2015 Jul; 51(7):696-8. PubMed ID: 25594910
[TBL] [Abstract][Full Text] [Related]
19. Food anaphylaxis in schools: evaluation of the management plan and the efficiency of the emergency kit.
Moneret-Vautrin DA; Kanny G; Morisset M; Flabbee J; Guénard L; Beaudouin E; Parisot L
Allergy; 2001 Nov; 56(11):1071-6. PubMed ID: 11703221
[TBL] [Abstract][Full Text] [Related]
20. Omalizumab prevents anaphylaxis and improves symptoms in systemic mastocytosis: Efficacy and safety observations.
Broesby-Olsen S; Vestergaard H; Mortz CG; Jensen B; Havelund T; Hermann AP; Siebenhaar F; Møller MB; Kristensen TK; Bindslev-Jensen C;
Allergy; 2018 Jan; 73(1):230-238. PubMed ID: 28662309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
